Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biotech funding trends [[electronic resource] ] : insights from entrepreneurs and investors / / Alexandra Carina Gruber
| Biotech funding trends [[electronic resource] ] : insights from entrepreneurs and investors / / Alexandra Carina Gruber |
| Autore | Gruber Alexandra Carina <1971-> |
| Pubbl/distr/stampa | Weinheim, : Wiley-Blackwell, c2009 |
| Descrizione fisica | 1 online resource (212 p.) |
| Disciplina |
228.4/36606094
338.476606 |
| Soggetto topico |
Biotechnology industries - Europe - Finance
Biotechnology - Europe |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-68309-8
9786612683091 3-527-62273-X 3-527-62274-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Biotech Funding Trends: Insights from Entrepreneurs and Investors; Contents; Preface; Acknowledgments; Limit of Liability/Disclaimer of Warranty; Executive Summary; 1 Introduction; 1.1 Development of the Private Equity and Venture Capital Market; 1.1.1 Denition; 1.1.2 Historical Background; 1.1.3 The Challenges to Private Equity in Europe; 1.1.4 Private Equity and Venture Capital Performance in Europe by Country; 1.1.5 The Future of Private Equity and Venture Capital in Europe; 1.2 Development of the Biotech Industry; 1.2.1 Definition; 1.2.2 Historical Background
1.2.3 Financing Biotech Start-ups1.2.4 Exit Routes in the Biotech Industry; 1.2.5 The Challenges to European Biotech; 1.2.6 The Future of the European Biotech Industry; 2 Methodology; 2.1 Formulating the Research Goal; 2.1.1 The Entrepreneur's Dilemma; 2.1.2 The Investor's Dilemma; 2.1.3 Financing Models; 2.1.4 Interpersonal Relationships and Cooperations; 2.1.5 Practical Guidelines for Entrepreneurs and Venture Capitalists; 2.2 Conducting the Study; 2.2.1 Qualitative Interviews; 2.2.2 Selection of Interview Partners; 2.3 Evaluating the Results; 3 Data Analysis and Interpretation of Results 3.1 Description of Interview Partners3.1.1 Entrepreneurs; 3.1.2 Venture Capitalists; 3.1.3 Other Investors; 3.2 Major Characteristics of an Entrepreneur; 3.2.1 The Dual Role of the Entrepreneur; 3.3 Major Characteristics of a Venture Capitalist; 3.3.1 Global Reach of the Fund; 3.4 The Most Important Partnering Criteria; 3.4.1 The Entrepreneur's Perspective; 3.4.2 The Venture Capitalist's Perspective; 3.4.3 The Perspective of Other Investors; 3.5 Financing Models; 3.5.1 Most Important Financing Models; 3.5.2 New and Creative Financing Approaches 3.5.3 Differences Between Early- and Late-stage Financing3.5.4 Differences Between Early- and Late-stage Valuation Techniques; 3.6 Biotech Research Areas; 3.6.1 Vaccines; 3.6.2 Biotech Drug Development or Medical Technology and Devices?; 3.7 Alliances and Funding in the Early Stage; 3.7.1 Networking Between Venture Capitalists and Universities and Their Scientists; 3.7.2 The Role of Government Grants; 3.7.3 The Role of Business Angels; 3.7.4 Preferred Deal Structure; 3.7.5 Structuring the Board of Directors; 3.8 Alliances and Funding in the Late Stage 3.8.1 Networking with Corporate Venture Capitalists3.8.2 The Role of Banks as Capital Investors; 3.8.3 The Importance of Milestone Payments; 3.9 Exit Routes; 3.9.1 Exit Preferences; 3.9.2 The Role of New Markets; 3.9.3 Prominent European IPO Success Stories; 3.10 Primary Causes of Failure; 3.10.1 The Entrepreneur's Perspective; 3.10.2 The Venture Capitalist's Perspective; 3.10.3 The Perspective of Other Investors; 3.11 Best-practice Countries for Funding Biotech Start-ups; 3.11.1 The Entrepreneur's Perspective; 3.11.2 The Venture Capitalist's Perspective 3.11.3 The Perspective of Other Investors |
| Record Nr. | UNINA-9910145252003321 |
Gruber Alexandra Carina <1971->
|
||
| Weinheim, : Wiley-Blackwell, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biotech funding trends [[electronic resource] ] : insights from entrepreneurs and investors / / Alexandra Carina Gruber
| Biotech funding trends [[electronic resource] ] : insights from entrepreneurs and investors / / Alexandra Carina Gruber |
| Autore | Gruber Alexandra Carina <1971-> |
| Pubbl/distr/stampa | Weinheim, : Wiley-Blackwell, c2009 |
| Descrizione fisica | 1 online resource (212 p.) |
| Disciplina |
228.4/36606094
338.476606 |
| Soggetto topico |
Biotechnology industries - Europe - Finance
Biotechnology - Europe |
| ISBN |
1-282-68309-8
9786612683091 3-527-62273-X 3-527-62274-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Biotech Funding Trends: Insights from Entrepreneurs and Investors; Contents; Preface; Acknowledgments; Limit of Liability/Disclaimer of Warranty; Executive Summary; 1 Introduction; 1.1 Development of the Private Equity and Venture Capital Market; 1.1.1 Denition; 1.1.2 Historical Background; 1.1.3 The Challenges to Private Equity in Europe; 1.1.4 Private Equity and Venture Capital Performance in Europe by Country; 1.1.5 The Future of Private Equity and Venture Capital in Europe; 1.2 Development of the Biotech Industry; 1.2.1 Definition; 1.2.2 Historical Background
1.2.3 Financing Biotech Start-ups1.2.4 Exit Routes in the Biotech Industry; 1.2.5 The Challenges to European Biotech; 1.2.6 The Future of the European Biotech Industry; 2 Methodology; 2.1 Formulating the Research Goal; 2.1.1 The Entrepreneur's Dilemma; 2.1.2 The Investor's Dilemma; 2.1.3 Financing Models; 2.1.4 Interpersonal Relationships and Cooperations; 2.1.5 Practical Guidelines for Entrepreneurs and Venture Capitalists; 2.2 Conducting the Study; 2.2.1 Qualitative Interviews; 2.2.2 Selection of Interview Partners; 2.3 Evaluating the Results; 3 Data Analysis and Interpretation of Results 3.1 Description of Interview Partners3.1.1 Entrepreneurs; 3.1.2 Venture Capitalists; 3.1.3 Other Investors; 3.2 Major Characteristics of an Entrepreneur; 3.2.1 The Dual Role of the Entrepreneur; 3.3 Major Characteristics of a Venture Capitalist; 3.3.1 Global Reach of the Fund; 3.4 The Most Important Partnering Criteria; 3.4.1 The Entrepreneur's Perspective; 3.4.2 The Venture Capitalist's Perspective; 3.4.3 The Perspective of Other Investors; 3.5 Financing Models; 3.5.1 Most Important Financing Models; 3.5.2 New and Creative Financing Approaches 3.5.3 Differences Between Early- and Late-stage Financing3.5.4 Differences Between Early- and Late-stage Valuation Techniques; 3.6 Biotech Research Areas; 3.6.1 Vaccines; 3.6.2 Biotech Drug Development or Medical Technology and Devices?; 3.7 Alliances and Funding in the Early Stage; 3.7.1 Networking Between Venture Capitalists and Universities and Their Scientists; 3.7.2 The Role of Government Grants; 3.7.3 The Role of Business Angels; 3.7.4 Preferred Deal Structure; 3.7.5 Structuring the Board of Directors; 3.8 Alliances and Funding in the Late Stage 3.8.1 Networking with Corporate Venture Capitalists3.8.2 The Role of Banks as Capital Investors; 3.8.3 The Importance of Milestone Payments; 3.9 Exit Routes; 3.9.1 Exit Preferences; 3.9.2 The Role of New Markets; 3.9.3 Prominent European IPO Success Stories; 3.10 Primary Causes of Failure; 3.10.1 The Entrepreneur's Perspective; 3.10.2 The Venture Capitalist's Perspective; 3.10.3 The Perspective of Other Investors; 3.11 Best-practice Countries for Funding Biotech Start-ups; 3.11.1 The Entrepreneur's Perspective; 3.11.2 The Venture Capitalist's Perspective 3.11.3 The Perspective of Other Investors |
| Record Nr. | UNINA-9910830703703321 |
|
Gruber Alexandra Carina <1971->
|
||
| Weinheim, : Wiley-Blackwell, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biotech funding trends [[electronic resource] ] : insights from entrepreneurs and investors / / Alexandra Carina Gruber
| Biotech funding trends [[electronic resource] ] : insights from entrepreneurs and investors / / Alexandra Carina Gruber |
| Autore | Gruber Alexandra Carina <1971-> |
| Pubbl/distr/stampa | Weinheim, : Wiley-Blackwell, c2009 |
| Descrizione fisica | 1 online resource (212 p.) |
| Disciplina |
228.4/36606094
338.476606 |
| Soggetto topico |
Biotechnology industries - Europe - Finance
Biotechnology - Europe |
| ISBN |
1-282-68309-8
9786612683091 3-527-62273-X 3-527-62274-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Biotech Funding Trends: Insights from Entrepreneurs and Investors; Contents; Preface; Acknowledgments; Limit of Liability/Disclaimer of Warranty; Executive Summary; 1 Introduction; 1.1 Development of the Private Equity and Venture Capital Market; 1.1.1 Denition; 1.1.2 Historical Background; 1.1.3 The Challenges to Private Equity in Europe; 1.1.4 Private Equity and Venture Capital Performance in Europe by Country; 1.1.5 The Future of Private Equity and Venture Capital in Europe; 1.2 Development of the Biotech Industry; 1.2.1 Definition; 1.2.2 Historical Background
1.2.3 Financing Biotech Start-ups1.2.4 Exit Routes in the Biotech Industry; 1.2.5 The Challenges to European Biotech; 1.2.6 The Future of the European Biotech Industry; 2 Methodology; 2.1 Formulating the Research Goal; 2.1.1 The Entrepreneur's Dilemma; 2.1.2 The Investor's Dilemma; 2.1.3 Financing Models; 2.1.4 Interpersonal Relationships and Cooperations; 2.1.5 Practical Guidelines for Entrepreneurs and Venture Capitalists; 2.2 Conducting the Study; 2.2.1 Qualitative Interviews; 2.2.2 Selection of Interview Partners; 2.3 Evaluating the Results; 3 Data Analysis and Interpretation of Results 3.1 Description of Interview Partners3.1.1 Entrepreneurs; 3.1.2 Venture Capitalists; 3.1.3 Other Investors; 3.2 Major Characteristics of an Entrepreneur; 3.2.1 The Dual Role of the Entrepreneur; 3.3 Major Characteristics of a Venture Capitalist; 3.3.1 Global Reach of the Fund; 3.4 The Most Important Partnering Criteria; 3.4.1 The Entrepreneur's Perspective; 3.4.2 The Venture Capitalist's Perspective; 3.4.3 The Perspective of Other Investors; 3.5 Financing Models; 3.5.1 Most Important Financing Models; 3.5.2 New and Creative Financing Approaches 3.5.3 Differences Between Early- and Late-stage Financing3.5.4 Differences Between Early- and Late-stage Valuation Techniques; 3.6 Biotech Research Areas; 3.6.1 Vaccines; 3.6.2 Biotech Drug Development or Medical Technology and Devices?; 3.7 Alliances and Funding in the Early Stage; 3.7.1 Networking Between Venture Capitalists and Universities and Their Scientists; 3.7.2 The Role of Government Grants; 3.7.3 The Role of Business Angels; 3.7.4 Preferred Deal Structure; 3.7.5 Structuring the Board of Directors; 3.8 Alliances and Funding in the Late Stage 3.8.1 Networking with Corporate Venture Capitalists3.8.2 The Role of Banks as Capital Investors; 3.8.3 The Importance of Milestone Payments; 3.9 Exit Routes; 3.9.1 Exit Preferences; 3.9.2 The Role of New Markets; 3.9.3 Prominent European IPO Success Stories; 3.10 Primary Causes of Failure; 3.10.1 The Entrepreneur's Perspective; 3.10.2 The Venture Capitalist's Perspective; 3.10.3 The Perspective of Other Investors; 3.11 Best-practice Countries for Funding Biotech Start-ups; 3.11.1 The Entrepreneur's Perspective; 3.11.2 The Venture Capitalist's Perspective 3.11.3 The Perspective of Other Investors |
| Record Nr. | UNINA-9910841167403321 |
|
Gruber Alexandra Carina <1971->
|
||
| Weinheim, : Wiley-Blackwell, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||